Black Friday 25% off both GutID tests, through Cyber Monday. No code needed. 25% off both tests, through Cyber Monday Shop the sale
Free shipping both waysResults 4–5 weeks after lab receipt

Gut Zoomer vs. GI Effects vs. GI360: Comprehensive Stool Test Comparison

Gut Zoomer, GI Effects® and GI360™ are comprehensive stool panels, but each pairs a different set of laboratory methods. Genova Diagnostics' GI Effects Comprehensive Profile and Doctor's Data's GI360 both combine PCR with bacterial and yeast culture, MALDI-TOF identification, susceptibility testing, microscopy and stool chemistries, while Vibrant Wellness's Gut Zoomer uses PCR-based detection, immunoassays and mass spectrometry and, in its current version, adds urine neurotransmitter markers. Which one fits depends on whether you need cultured isolates, specific markers such as bile acids or neurotransmitters, and a collection and billing setup the patient can manage.

GutID starts from a different place: the bacterial community itself. Its Titan-1™ long-read sequencing reads one continuous ~2,500-base stretch of each bacterium's ribosomal DNA to see the entire bacterial ecosystem, an approach backed by 30+ peer-reviewed publications. GutID Pro puts that ecosystem and 65 targeted markers, including enteric bacteria, viruses, parasites, Candida, calprotectin and elastase, in one kit.

This comparison is for practitioners weighing these panels, using each lab's published materials at time of writing (October 2026).

Gut Zoomer vs. GI Effects vs. GI360 at a glance

Attribute Gut Zoomer (Vibrant Wellness) GI Effects® Comprehensive Profile (Genova Diagnostics) GI360™ (Doctor's Data; also via MosaicDX) GutID Pro
Who orders it A licensed provider A provider through myGDX; consumers can also buy it through Genova Connect A practitioner; no direct patient orders An approved clinician in the US, for patients 18 and over
Microbiome method More than 100 commensal species (Vibrant names deep metagenomic PCR among its methods); Shannon and Simpson indices 16S rRNA qPCR on 24 commensal genera and species; two dysbiosis scores Multiplex PCR on 45-plus analytes; Dysbiosis Index and Diversity score Titan-1™ long-read sequencing of one ~2,500-base fragment (full 16S, ITS, start of 23S); species-level identification with relative abundance; 31 commensal and dysbiotic markers
Culture and susceptibility Not among Vibrant's listed methods Bacterial and yeast culture with MALDI-TOF; sensitivities for cultured pathogens Bacterial and yeast culture with MALDI-TOF; susceptibility to antibiotics and natural or botanical agents Not included
Parasites Within its 76-pathogen list Ova-and-parasite microscopy plus PCR for six protozoa Ova-and-parasite microscopy plus pathogen PCR Six parasites on the included GI panel
Other markers Calprotectin and other inflammation markers; antibody and malabsorption markers; FIT, zonulin, elastase, secretory IgA and pH; bile acids, short-chain fatty acids and β-glucuronidase; urine neurotransmitters Elastase-1, protein breakdown products, fecal fat, calprotectin, eosinophil protein X, secretory IgA, occult blood, short-chain fatty acids, β-glucuronidase Calprotectin, lactoferrin, lysozyme, elastase, fat, carbohydrates, secretory IgA, pH, occult blood, short-chain fatty acids, β-glucuronidase Twelve enteric bacteria, six enteric viruses and six Candida species, plus C. difficile toxin NAAT; quantitative calprotectin, pancreatic elastase-1, fecal occult blood; H. pylori stool antigen
Sample Stool (two tubes) plus timed urine; mailed within 24 hours Stool; one-day or three-day collection Stool over one to three days; refrigerated and frozen vials One stool collection, two tubes
Results time Vibrant lists 7 days; its how-it-works steps say 2–3 weeks to the provider Typically 7–17 days after receipt, up to 27 days for some methods (Genova Connect) 6–8 days per Doctor's Data; 1–2 weeks per MosaicDX (both estimates) 3–4 weeks after the lab receives the sample
Published price None; cash pay $474 plus a $15 physician fee on Genova Connect None; MosaicDX provides superbills None; approved clinicians sign in for pricing
New York Separate New York configuration Some Genova products unavailable; Genova Connect excludes NY, NJ and RI Not offered Not available in New York State
Best suited to One order spanning microbes, digestion, antibodies, metabolites and gut–brain markers Culture plus a fixed qPCR commensal panel, with an optional shotgun add-on Culture and susceptibilities alongside a PCR dysbiosis index The entire bacterial ecosystem plus 65 targeted markers from one collection

How each test works

Gut Zoomer

Vibrant markets the current Gut Zoomer without a version number and says it uses different methods for different marker groups, naming deep metagenomic PCR, high-specificity pathogen detection, sandwich ELISA and LC-MS/MS. The marker list runs from more than 100 commensal species and 76 pathogens, including parasites, to the digestion, inflammation, antibody and metabolite markers in the table above. The current page also lists neurotransmitter markers from timed urine samples, and a separate configuration serves patients in New York.

GI Effects Comprehensive Profile

Genova arranges the profile into digestion and absorption, inflammation and immunology, and the gut microbiome. Commensals are measured by 16S rRNA gene qPCR across 24 genera and species that map to seven phyla, and Genova reports an Inflammation-Associated Dysbiosis score and a Methane Dysbiosis score with short-chain fatty acids and β-glucuronidase. Bacteria and yeast are cultured and identified by MALDI-TOF, with sensitivities for cultured pathogenic organisms, and parasitology pairs an ova-and-parasite exam with real-time PCR for six protozoa, including Blastocystis, Cryptosporidium and Giardia.

Add-ons include H. pylori, fecal lactoferrin, zonulin family peptide and Genova's Microbiomix shotgun metagenomic sequencing profile, which has a 30-day turnaround.

GI360

GI360 builds on Doctor's Data's Comprehensive Stool Analysis with a multiplex PCR platform that profiles more than 45 bacterial analytes across six phyla and scores them as a Dysbiosis Index and a Diversity score on 1–5 scales. A separate PCR panel targets 14 pathogenic bacteria, viruses and parasites. Culture with MALDI-TOF identification feeds susceptibility testing against antibiotics and natural or botanical agents, while microscopy and biochemical assays supply the ova-and-parasite exam and stool chemistries. Doctor's Data offers GI360 directly; MosaicDX also lists it, and its sample report names Doctor's Data, Inc. as the performing laboratory.

Key differences

  • Culture. GI Effects and GI360 both culture bacteria and yeast, identify them by MALDI-TOF and report susceptibility results. Vibrant's published methods for the Gut Zoomer do not include culture.
  • Commensal profiling. GI Effects reports a fixed set of 24 genera and species by 16S rRNA qPCR, GI360 reports 45-plus analytes by multiplex PCR, and the Gut Zoomer reports more than 100 commensal species, each with its own summary scores. GutID Pro sequences the community itself.
  • Collection. GI Effects offers a one-day or three-day collection; GI360 uses up to three days, with refrigerated and frozen vials; the Gut Zoomer pairs one stool collection with timed urine samples shipped within 24 hours; GutID Pro uses one collection, two tubes.
  • Access and billing. Genova Connect sells the #2200 profile to consumers for $474 plus a $15 physician fee at time of writing, with no insurance billing on that route. Vibrant and MosaicDX publish no prices: Vibrant is cash pay only, and MosaicDX provides superbills instead of filing claims. All three routes accept HSA or FSA payment.

When the Gut Zoomer is the right choice

  • You want microbes, digestion and malabsorption, antibody markers, bile acids and short-chain fatty acids in one order.
  • Gut–brain concerns make the urine neurotransmitter markers relevant.
  • The patient is in New York, where Vibrant offers a separate configuration.

When GI Effects is the right choice

  • You want culture with sensitivities and an ova-and-parasite exam backed by protozoan PCR.
  • A fixed qPCR commensal panel with inflammation-associated and methane dysbiosis scores fits the case, with Microbiomix as an optional shotgun add-on (see our 16S, shotgun and long-read sequencing explainer).
  • The patient prefers to buy directly through Genova Connect.

When GI360 is the right choice

  • Susceptibility results that include natural and botanical agents would guide your plan.
  • You want a PCR Dysbiosis Index next to culture, microscopy and a full set of stool chemistries, and the patient can manage up to three collection days with cold storage.

When GutID Pro is the better choice

  • You want the entire bacterial ecosystem (diversity, balance, which species are present in what relative abundance, and how that shifts over time) rather than a defined list of commensal targets.
  • You want enteric bacteria, viruses, parasites, Candida, calprotectin, elastase and H. pylori antigen on the same report as that ecosystem, from one collection.
  • One collection suits the patient better than several days of stool or timed urine.

Before any of these tests, anyone with red-flag symptoms (blood in the stool, unexplained weight loss, fever, or severe or persistent diarrhea) or a suspected acute infection should see a clinician for diagnostic testing.

Where GI-MAP fits

GI-MAP® from Diagnostic Solutions Laboratory runs qPCR on one stool sample shipped at room temperature, with insurance and Medicare billing available. Our head-to-head pages compare it with each panel: GI-MAP vs. Gut Zoomer, GI-MAP vs. GI Effects and GI-MAP vs. GI360.

Why GutID sees more

These panels' commensal sections report defined lists (24 targets in GI Effects, 45-plus in GI360, more than 100 species in the Gut Zoomer), and an organism that isn't on a list doesn't appear. Titan-1™ reads the community instead: a patented amplicon yields one continuous ~2,500-base fragment of each bacterium's ribosomal DNA, covering the full 16S gene, the internal transcribed spacer (ITS) and the start of 23S, read repeatedly into a consensus. That is 5–10 times more ribosomal DNA per bacterium than a short-read 16S test reads.

GutID's own classifier identifies organisms from the whole long read instead of matching short markers to a fixed database, so it separates and quantifies organisms even when no species name exists. The report turns that strain-level data into species-level identification with relative abundance. When Gehrig et al. (Microbial Genomics, 2022) compared short-read 16S with a long-read 16S–ITS–23S amplicon, only the long read gave strain-level community resolution and insight into novel taxa, and the approach behind Titan-1 is backed by 30+ peer-reviewed publications.

GutID Pro adds 65 markers. A CLIA laboratory runs the included panels on a second tube from the same collection: twelve enteric bacteria, six enteric viruses, six parasites and six Candida species, with C. difficile toxin NAAT; quantitative calprotectin, pancreatic elastase-1 and fecal occult blood; and H. pylori stool antigen. Thirty-one commensal and dysbiotic markers, each with its own reference range, round out a single report, with results in 3–4 weeks. Clinicians can request an account or browse the sample report.

Frequently asked questions

What is the best comprehensive stool test?

It depends on the question. GI Effects and GI360 both provide culture and susceptibility results, the Gut Zoomer lists bile acids, antibody markers and urine neurotransmitters, and GI-MAP uses one room-temperature sample with insurance billing. For the entire bacterial ecosystem plus targeted markers in one kit, choose GutID Pro.

GI 360 vs. GI Effects: what is the difference?

Both combine PCR, culture with MALDI-TOF identification and microscopy. They differ in microbiome method (multiplex PCR with a 1–5 Dysbiosis Index for GI360; 16S rRNA qPCR on 24 targets for GI Effects), in GI360's susceptibility testing of natural and botanical agents, and in access: Genova sells GI Effects to consumers through Genova Connect, while GI360 requires a practitioner.

Gut Zoomer vs. GI Effects: how do they compare?

GI Effects relies on culture, microscopy and a fixed qPCR commensal panel, with Microbiomix available for shotgun sequencing. The Gut Zoomer uses PCR, immunoassays and mass spectrometry across more than 100 commensals, 76 pathogens, metabolites including bile acids, and urine neurotransmitters.

Gut Zoomer vs. GI 360: which one includes culture?

GI360 does: it cultures bacteria and yeast, identifies them by MALDI-TOF and reports susceptibilities. Vibrant lists the Gut Zoomer's methods as PCR-based detection, sandwich ELISA and LC-MS/MS.

How much do these stool tests cost?

At time of writing, Genova Connect lists the GI Effects #2200 profile at $474 plus a $15 physician fee. Vibrant, Doctor's Data and MosaicDX do not publish Gut Zoomer or GI360 prices, so ask the ordering provider.

Is GutID better than Gut Zoomer, GI Effects or GI360?

For seeing the entire bacterial ecosystem, yes. Those panels report defined lists of commensal targets, while Titan-1 reads 5–10 times more of each bacterium's ribosomal DNA than a short-read 16S test, identifies organisms a fixed panel can't, including ones with no species name yet, and is backed by 30+ peer-reviewed publications. GutID Pro adds 65 targeted markers in the same kit. For cultured isolates or urine neurotransmitters, see the sections above.

What does GutID Pro add?

The full Complete Microbiome Assessment, plus 65 more markers: lab panels run on a second tube from the same collection (a GI panel of enteric bacteria, enteric viruses, parasites and Candida species, with C. difficile toxin NAAT, plus calprotectin, pancreatic elastase-1, fecal occult blood and H. pylori stool antigen) and 31 commensal and dysbiotic markers. Patients can't buy it directly but can ask their clinician; approved US clinicians order it for patients 18 and over, outside New York State.

Sources

  1. Gut Zoomer — Vibrant Wellness (accessed October 30, 2026)
  2. Stool Sample Collection Instructions — Vibrant Wellness (accessed October 30, 2026)
  3. Billing, Payment & Insurance Information — Vibrant Wellness (accessed October 30, 2026)
  4. Vibrant Wellness Brings the Most Comprehensive Gut Health Test to New York — Vibrant Wellness via Newswire (accessed October 30, 2026)
  5. GI Effects® Stool Profiles — Genova Diagnostics (accessed October 30, 2026)
  6. Gut Health Test — Genova Connect (Genova Diagnostics) (accessed October 30, 2026)
  7. Microbiomix — Genova Diagnostics (accessed October 30, 2026)
  8. GI360 Stool Profile — Doctor's Data (accessed October 30, 2026)
  9. GI360™ Profile — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  10. Sample Report GI360 — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  11. Comprehensive Stool Analysis and GI360 Profile Collection Instructions — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  12. How Our Payment Methods and Procedures Work — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  13. Ordering Labs FAQ — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  14. GI-MAP — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  15. Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data (Gehrig et al., 2022) — Microbial Genomics (accessed October 30, 2026)

GutID provides wellness and educational insights and is not a diagnostic test. GI Effects®, GI360™, GI-MAP®, Gut Zoomer and Microbiomix are trademarks of their respective owners. GutID is not affiliated with Genova Diagnostics, Vibrant Wellness, Doctor's Data, Mosaic Diagnostics or Diagnostic Solutions Laboratory.

This article is for education and is not medical advice. GutID provides wellness and educational insights and is not a diagnostic test.

Read two real sample reports.

Two full reports from one de-identified person, before and after an intervention, sent to your inbox.